Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
(7S,10S,13S,16S,19S)-19-((2S,5S,8S,11S,14S)-14-amino-2,11-bis(4-aminobutyl)-5-benzyl-8-(3-guanidinopropyl)-15-methyl-4,7,10,13-tetraoxo-3,6,9,12-tetraazahexadecanamido)-13,16-dibenzyl-N-((2S,5S,8S,11S,14S)-5,8-bis(4-aminobutyl)-11-benzyl-14-carbamoyl-15-methyl-3,6,9,12-tetraoxo-1-phenyl-4,7,10,13-tetraazahexadecan-2-yl)-10-(3-guanidinopropyl)-9,12,15,18-tetraoxo-2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23,24,25-tetracosahydro-1H-benzo[r][1,4,7,10,16,21]hexaazacycloheptacosine-7-carboxamide
ID: ALA5208987
PubChem CID: 168296877
Max Phase: Preclinical
Molecular Formula: C111H168N28O15
Molecular Weight: 2134.75
Associated Items: